Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON24935Recruiting
Trial of atomoxetine in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Utrecht University. Primary endpoints: Standard Deviation of Lateral Position, P3a in auditory oddball task and 2 more. Started Sep 2009; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON24935.